IGF2BP3 and familial pancreatic carcinoma: Immunohistochemistry results for IGF2BP3, PAIP2B, and SIDT2 have already been shown in Figure 2, and we additionally present the results for the rest of the five RBPs in pancreatic cancer tissues as shown in Supplementary Figure S4, which strongly validate their expression in patient samples signifying their importance in the disease.